Sonnet BioTherapeutics Holdings Inc SONN announced that pharmacokinetic (PK) profile simulation of SON-1010 dosing had been completed in its Phase 1 trial in healthy volunteers. The Safety Review Committee has…
Neuronetics Inc STIM and Greenbrook TMS Inc GBNH announced an expanded commercial partnership through year-end 2028. Under the partnership agreement, Neuronetics will be the exclusive supplier of transcranial magnetic stimulation (TMS) equipment…
Citigroup Inc C has reportedly discriminated against the firearms sector, the office of Texas Attorney General Ken Paxton said, making a decision that “has the effect” of halting the bank’s…
XORTX Therapeutics Inc XRTX has announced topline results from the XRX-OXY-101 – Bridging Pharmacokinetics Clinical Trial characterizing the pharmacokinetics of formulated oral oxypurinol, XORLO. The study showed that XORLO was well…
Personalis Inc PSNL approved a reduction in the company’s workforce by up to approximately 30% to reduce operating costs and improve operating efficiency. The reduction in workforce is expected to be…
The Janssen Pharmaceutical Companies of Johnson & Johnson JNJ announced the results of an independent, scheduled data review of the Phase 3 Mosaico study of the investigational HIV vaccine regimen. …
Horizon Therapeutics plc’s HZNP Phase 2 trial evaluating dazodalibep for Sjögren’s syndrome met its primary endpoint in the second patient population. Sjogren’s syndrome is an immune system disorder identified by…
RenovoRx Inc RNXT announced initial results from a pharmacokinetic (PK) substudy within the phase 3 un-blinded randomized control TIGeR-PaC clinical trial to be presented at the 2023 ASCO Gastrointestinal (ASCO GI) Cancers…
Ontrak Inc OTRK announced initial assessment results showing that after six months, 30% of assessed Ontrak Wholehealth+ members sustained a clinically significant reduction in anxiety symptoms, and 55% sustained a clinically significant…
Calyxt Inc CLXT has agreed to merge with Cibus in an all-stock transaction to create a company focused on agriculture-based gene editing and establish facilities for trait development and next-generation plant breeding. Productivity…
The Association of the British Pharmaceutical Industry (ABPI) said pharmaceutical giants AbbVie Inc ABBV and Eli Lilly And Co LLY have withdrawn from Britain’s voluntary medicines pricing agreement. Companies are increasingly arguing that it…
The founders of a bankrupt crypto hedge-fund firm, Three Arrows Capital Ltd, are reportedly looking for capital infusion to launch an exchange where creditors to insolvent digital-assets firms, including their own,…
The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) are investigating a “preliminary signal” of the likelihood of a stroke among elderly people…
Splitit Payments Ltd SPTTY and Alipay have formed a partnership to power the ‘Pay After Delivery’ option for shoppers on AliExpress, a global eCommerce marketplace owned by Chinese internet giant Alibaba Group Holding Ltd BABA. Splitit’s technology…
Wells Fargo & Co WFC reported a Q4 net income of $2.85 billion, down 53% Y/Y and 20% sequentially, driven partly by lower mortgage banking. The company posted an EPS…
Starbucks Corporation SBUX has asked its corporate employees to be in the office at least three days a week. “Effective Jan. 30, Starbucks employees within commuting distance would be…
P3 Health Partners Inc PIII provided preliminary 2023 sales guidance of $1.20 billion-$1.25 billion, compared to the consensus of $1.30 billion. The company expects an adjusted EBITDA loss of $(40)…
Boeing Co BA boosted deliveries by 41% in 2022 over the previous year to 480 commercial jets, while Airbus SE EADSY EADSF annual deliveries increased 8% to 661. It marked the fourth consecutive year for…
Sutro Biopharma Inc STRO announced results from a Phase 1 dose-expansion study of STRO-002 (luvelta) and interim safety data from exploratory cohort C of advanced ovarian cancer treated at the higher dose…
RBC Capital Markets upgraded Stryker Corporation SYK from sector Perform to Outperform, with a price target of $284, up from $240, citing potential tailwinds that position the company to deliver upside to sales…